Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on April 23, 2015. The filing reports a corporate governance event: the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on director compensation arrangements rather than operational financial performance.
- Director Retainer: $85,000 per year.
- Annual Equity Award: Restricted stock units with a grant date fair value of $120,000.
- Meeting Fees: $1,500 for in-person attendance; $1,000 for telephonic attendance.
Material Changes
On April 23, 2015, the Board of Directors appointed Michael Montelongo as a Class III member of the Board. Mr. Montelongo was not appointed to any Board committees. There were no special arrangements or understandings regarding his appointment.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. The only forward-looking element is the confirmation that Mr. Montelongo will participate in the existing non-management director compensation program.
Investor Verification Checklist
- Verify the effective date of Michael Montelongo's board membership.
- Confirm the total annual compensation package for non-management directors ($205,000 base plus meeting fees).
- Review the attached press release (Exhibit 99.1) for additional biographical details on the new director.
- Check subsequent filings for any committee assignments for Mr. Montelongo.